Leukemia & Lymphoma
Efficacy and safety of rituximab plus low-dose oral fludarabine and cyclophosphamide as first-line treatment of elderly patients with indolent non-Hodgkin lymphomas / Fabbri, A; Cencini, E; Rigacci, L; Bartalucci, G; Puccini, B; Dottori, R; Gozzetti, A; Bosi, A; Bocchia, M.. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - ELETTRONICO. - (2014), pp. 781-785.
Efficacy and safety of rituximab plus low-dose oral fludarabine and cyclophosphamide as first-line treatment of elderly patients with indolent non-Hodgkin lymphomas.
BOSI, ALBERTO;
2014
Abstract
Leukemia & LymphomaFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.